World Hypertension League Upon "Call to Action for Global Hypertension Control" (全球发稿、全球发布新闻)

发布日期:2021-04-27 16:06

Rome, Italy - April 20, 2021:The European Society of Hypertension-International Society of Hypertension hosted a Joint Conference virtually this year amid the Global Pandemic of COVID-19. The title of this virtual joint international conference was ‘ESH-ISH HYPERTENSION 2021’, and it was held from April 11-14, 2021 with live broadcast worldwide. Over 5,000 professionals in hypertension and related fields from around the world participated in this conference, and it focused primarily on Implementing the Call to Action for Global Hypertension Control.

The President of the World Hypertension League, Professor Xin-Hua Zhang gave a speech on "Announcing and Promoting of the Call to Action for Global Hypertension Control". This speech was drafted by the World Hypertension League along with its global partners and member organizations. (全球发稿、全球发布新闻)

According to the World Hypertension Congress that was held in São Paulo, Brazil in 2019, despite being controllable, hypertension is not yet being properly controlled leading risk factor for death and disability worldwide. There are more than 1.4 billion hypertensive patients around the world but only less than 14% have their blood pressure under control. (全球发稿、全球发布新闻)

The ESH-ISH HYPERTENSION 2021 called on global health authorities and medical professional societies to implement the following practices: 
1. Apply global best practices 
2. Help primary care services become the central for hypertension prevention and control 
3. Promote teamwork among medical and non-medical staff to create patient-centered care 
4. Use evidence-based standardized treatment protocol, and continue supply of high quality, affordable, and sustainable antihypertensive medications 
5. Detect patients through routine outpatient clinics and population screening programs, and control blood pressure in a timely manner 
6. Reward excellent leaders, programs, and organizations that dedicated in hypertension prevention and control initiatives. (全球发稿、全球发布新闻)

The HEARTS China Hypertension Control Project is a successful example in implementing the Call to action and applying the best clinical practice.

 Professor Xin-Hua Zhang shared the progress of the HEARTS Hypertension Control Project in Henan Province, China. It is well demonstrated the impact of implementing the "Call to Action on global Hypertension Control". The project is led by the governmental health authorities, supported by the expert committee, and implemented by primary care providers in about 1000 township hospitals and community health care centers. The project uses internationally verified devices for measurement of blood pressure, glucose, uric acid and lipid, and a web-based clinical support and quality monitoring system. The system connects the measurements to prescription platform, provides information to support clinicians' decision making on diagnosis, treatment and planning for follow-up. It also provides daily and weekly reports to inform the relevant government offices about the quality and progress of hypertension control in the areas, helped the health authorities to provide timely assistance and supervision to primary health care services. The project was launched in July 2018, and as of December 31, 2020, the number of primary care services participating in the HEARTS hypertension control project has increased from 54 to more than 800; and the registered hypertensive patients getting their blood pressure under control has increased from about 700 to more than 40,000.

The HEARTS technical package is a strategic and practical guidance developed by the World Health Organization and international medical professional societies. It aims to improve the capacity of primary care services in control and prevention of cardiovascular diseases. The package is intended for use by government health authorities, expert teams and primary care providers. It includes guidance on healthy lifestyles and patient self-management, evidence-based standardized treatment algorithm, high-quality uninterrupted supply of drugs and essential medical devices in the selected algorithm, risk-based management strategies, teamwork and shared responsibility, and a real-time quality monitoring system. The " Call to Action for Hypertension Control" recommends the HEARTS technical package as a best practice. (全球发稿、全球发布新闻)

Traditional Chinese medicines with RCT evidence of effectively reduced blood pressure should have a role in clinical practice for hypertension control. In primary care settings using evidence-based standardized treatment algorithm is the most effective way for improving hypertension control. The drugs in the algorithm must be evidence-based, long-acting, high-quality, affordable, available, and sustainable. The dose for every step and the pace for evaluation in the algorithm should also be supported by scientific evidence. In addition to globally recommended antihypertensive drugs, Chinese patent traditional medicines that meet the above criteria can also be selected. For example, "Songling Xuemaikang" has RCT evidence of effectively reduced blood pressure and improved lipid profile. It is well suitable for most patients at high risk of cardiovascular disease.

Finally, Professor Zhang concluded, "The results of the HEARTS hypertension control project in Henan, China, demonstrate that the ‘Call to Action' and it recommended best practices are implementable, replicable and sustainable. Widely dissemination of Call to Action can help improve the global hypertension control and help more hypertensive patients live longer and healthier."

SOURCE: The European Society of Hypertension